Add-on neurological benefits of antiviral therapy in HCV patients with chronic kidney disease — a nationwide cohort study

BACKGROUND: Hepatitis C virus (HCV)-infected patients with chronic kidney disease (CKD) have rarely been studied because they rarely accept interferon-based therapy (IBT) and have been difficult to follow up. We investigated long-term outcomes of IBT on the population. METHODS: This population-based...

Descripción completa

Detalles Bibliográficos
Autores principales: Lin, Ming-Shyan, Chen, Tien-Hsing, Lin, Wey-Yil, Liu, Chi-Hung, Hsieh, Yung-Yu, Chiu, Wen-Nan, Chang, Chih-Hsiang, Chen, Mei-Yen, Chung, Chang-Min, Lin, Yu-Sheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5559858/
https://www.ncbi.nlm.nih.gov/pubmed/28814273
http://dx.doi.org/10.1186/s12876-017-0653-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5559858/
https://www.ncbi.nlm.nih.gov/pubmed/28814273
http://dx.doi.org/10.1186/s12876-017-0653-2

Ejemplares similares